Cooper Companies (COO) Non-Current Deferred Tax Liability (2009 - 2026)
Cooper Companies (COO) recorded quarterly Non-Current Deferred Tax Liability of $96.4 million in Q2 2026, little changed quarter-over-quarter from $96.3 million in Q1 2026, and down 2.72% year-on-year from $99.1 million in Q2 2025.
Cooper Companies (COO) Non-Current Deferred Tax Liability (2009 - 2026) Analysis & Trends
Cooper Companies has disclosed Non-Current Deferred Tax Liability across 18 years of filings, most recently posting $96.4 million for Q2 2026.
- For the quarter ending Q2 2026, Non-Current Deferred Tax Liability fell 2.72% year-over-year to $96.4 million; the trailing twelve-month figure through Apr 2026 stood at $96.4 million (down 2.72% YoY), and the FY2025 full-year result was $93.3 million, down 69.76% from the prior year.
- Non-Current Deferred Tax Liability was $96.4 million for Q2 2026 at Cooper Companies, roughly flat from $96.3 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $308.5 million in Q4 2024 and troughed at $90.4 million in Q1 2024.
- The 5-year median for Non-Current Deferred Tax Liability is $101.2 million (2022), against an average of $133.5 million.
- The sharpest annual moves came in 2022 and 2025: Non-Current Deferred Tax Liability jumped 490.13% in 2022, then sank 69.76% in 2025.
- Year by year, Non-Current Deferred Tax Liability stood at $149.9 million in 2022, then jumped by 90.86% to $286.1 million in 2023, then increased by 7.83% to $308.5 million in 2024, then sank by 69.76% to $93.3 million in 2025, then climbed by 3.32% to $96.4 million in 2026.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $96.4 million in Q2 2026, $96.3 million in Q1 2026, and $93.3 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 96.40 Mn |
| Apr 30, 2026 | 96.40 Mn |
| Jan 31, 2026 | 96.30 Mn |
| Jan 31, 2026 | 96.30 Mn |
| Oct 31, 2025 | 93.30 Mn |
| Oct 31, 2025 | 93.30 Mn |
| Jul 31, 2025 | 101.80 Mn |
| Jul 31, 2025 | 101.80 Mn |
| Apr 30, 2025 | 99.10 Mn |
| Apr 30, 2025 | 99.10 Mn |
| Jan 31, 2025 | 95.20 Mn |
| Jan 31, 2025 | 95.20 Mn |
| Oct 31, 2024 | 308.50 Mn |
| Oct 31, 2024 | 308.50 Mn |
| Jul 31, 2024 | 94.90 Mn |
| Jul 31, 2024 | 94.90 Mn |
| Apr 30, 2024 | 94.20 Mn |
| Apr 30, 2024 | 94.20 Mn |
| Jan 31, 2024 | 90.40 Mn |
| Jan 31, 2024 | 90.40 Mn |